Browsing: Diabetes

Evidence summaries and landmark trials across type 1, type 2, prevention, glycaemic control, complications, and diabetes technology.

All

The Diabetes Control and Complications Trial demonstrated that intensive insulin therapy targeting near-normal blood glucose reduced the risk of developing retinopathy by 76% in primary prevention and slowed progression by 54% in secondary intervention, while also substantially reducing nephropathy and neuropathy, establishing the foundational evidence for tight glycaemic control in type 1 diabetes.